Previous close | 13.00 |
Open | 13.00 |
Bid | 11.75 |
Ask | 12.05 |
Strike | 115.00 |
Expiry date | 2023-01-20 |
Day's range | 12.02 - 13.10 |
Contract range | N/A |
Volume | |
Open interest | 1.13k |
mRNA blew open the door for more cold chain logistics business, helping UPS grow at twice the pace it had previously anticipated.
In anticipation of a new surge of COVID-19 infections later this year, the FDA recommends that COVID-19 vaccine manufacturers develop bivalent booster vaccines that contain the BA.4/BA.5 Omicron subvariants.
Life sciences company Thermo Fisher Scientific (NYSE: TMO) played an instrumental role in delivering COVID-19 treatments to the world's population. With healthcare spending on the rise, Thermo Fisher is expanding its services in a bid to capture even more of the market. To help address this need, The White House released a Pandemic Preparedness Plan and hopes to increase biodefense spending.